-
molecular mechanisms that cause the whole-body response to cancer. We employ pre-clinical and clinical research to develop and test new treatment strategies combining body reprogramming and anti-cancer
-
discovery and chemical biology. Our lab is working to understand the molecular mechanisms leading to efficient elicitation of tumor vulnerability for potent cancer targeting. We develop Targeted Protein
-
mechanisms, with a track record of creative research in molecular biology, cell biology, genomics, imaging approaches and/or bioinformatics. If selected for this position, you will be expected to: Develop and
-
of neural circuitry across rodent species to bridge this knowledge-gap. Position Requirements Candidates must hold a PhD degree (or equivalent) in neuroscience, biomedical engineering or a related field. The
-
outcome. The team uses a genetically engineered model of metastatic prostate cancer in a native, immune competent environment (see PMIDs: 24444712, 25829425 and 31092557). Recently, they developed whole